Tesamorelin therapy in Boise is available through Alturas Medical Weight Loss in nearby Meridian, Idaho! Tesamorelin is a prescription peptide that acts on the growth hormone-releasing hormone pathway.
It has been studied primarily for reducing visceral adipose tissue, commonly called visceral fat.
Made in the USA
Every peptide we prescribe is made in the United States
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone, or GHRH. It stimulates the body’s natural release of growth hormone.
Tesamorelin has received particular attention for its effects on visceral adipose tissue. Visceral fat is stored around internal organs within the abdominal cavity. This differs from subcutaneous fat, which sits directly beneath the skin.
Visceral fat surrounds internal organs and differs from the fat stored beneath the skin. Tesamorelin has been studied extensively for its effects on visceral adipose tissue.
Clinical trials have demonstrated reductions in visceral fat during tesamorelin treatment. One randomized trial studied adults with abdominal obesity and reduced growth hormone secretion. Tesamorelin produced a significant reduction in visceral adipose tissue compared with placebo.
Research outside the approved population remains more limited. These findings do not establish tesamorelin as a general weight-loss medication. The strongest approved evidence involves adults with HIV-associated lipodystrophy.
Yes. Tesamorelin is an FDA-approved prescription medication. The approved product is marketed under the EGRIFTA name.
The current FDA labeling is specific to adults with HIV-associated lipodystrophy. It is indicated for reducing excess abdominal fat in that population.
The FDA label specifically states that EGRIFTA is not indicated for weight-loss management. It also describes the medication as having a weight-neutral effect.
Use outside the approved indication should be discussed with a qualified prescriber. Your provider can explain the evidence, limitations and potential risks for your situation.
Sources
Where this information comes from
Last reviewed: October 2026
Tesamorelin is not appropriate for everyone. A medical evaluation at Alturas Medical Weight Loss should come before treatment.
We may review:
These factors help determine whether tesamorelin is medically appropriate. Body composition alone does not establish that tesamorelin is the right treatment.
Tesamorelin affects growth hormone and IGF-1 levels. Treatment therefore requires appropriate medical monitoring.
Potential adverse effects include injection-site reactions, joint pain and muscle pain. Tesamorelin can also affect glucose metabolism.
The FDA label warns about elevated IGF-1 levels and glucose intolerance. Important contraindications include active malignancy and pregnancy. Certain conditions involving the hypothalamic-pituitary axis also require consideration.
Long-term cardiovascular safety has not been established. These risks make medical evaluation an important part of treatment.
Tesamorelin is a prescription decision, not an online purchase. Every evaluation begins with a medical consultation.
We review your medical history, medications, goals and relevant laboratory results. If appropriate, Dr. Ashley Southern develops an individualized treatment plan.
Follow-up helps monitor your response and relevant health markers. Treatment may be adjusted based on your clinical response.
Alturas Medical Weight Loss is located in Meridian, Idaho, about 15 minutes from downtown Boise. Our clinic serves patients throughout Boise and the Treasure Valley. Patients also visit from Eagle, Star, Nampa, Caldwell and surrounding communities.
Alturas Medical Weight Loss
1532 W Cayuse Creek Dr, Suite 130
Meridian, ID 83646
(208) 690-2040
Tesamorelin is one of several peptide therapies available through our clinic, and every peptide we prescribe is made in the United States.
Dr. Ashley Southern is the physician and co-founder of Alturas Medical Weight Loss. She evaluates peptide therapy within the context of each patient’s medical history, medications and laboratory results.
The goal is to determine whether a specific therapy is medically appropriate.
Tesamorelin is one of several physician-prescribed peptides we offer at our Meridian clinic, near Boise. Every plan starts with a medical evaluation. Explore our full peptide therapy in Boise program or the related therapies below.
Bremelanotide, which acts on melanocortin receptors in the brain. The FDA-approved version (Vyleesi) is approved for low sexual desire in premenopausal women; other uses are off-label.
An investigational peptide fragment of thymosin beta-4, studied primarily in laboratory research involving tissue repair and wound healing.
A peptide that has been studied, mostly in animal research, for tendon, ligament and gut-lining repair. Used in certain physician-supervised recovery protocols.
A combination of BPC-157 and TB-500 considered in physician-supervised recovery protocols.
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone. It stimulates the body’s natural release of growth hormone.
Tesamorelin stimulates growth hormone release through the GHRH pathway. Clinical research has demonstrated reductions in visceral adipose tissue.
Tesamorelin has been shown to reduce visceral abdominal fat in clinical studies. Visceral fat differs from subcutaneous fat beneath the skin.
The FDA-approved product is not indicated for weight-loss management. The current FDA label describes its effect as weight neutral.
Yes. Tesamorelin is a synthetic peptide analogue of growth hormone-releasing hormone.
Yes. Tesamorelin increases IGF-1 levels during treatment. IGF-1 monitoring may therefore be relevant during treatment.
No. Tesamorelin and human growth hormone are different medications. Tesamorelin stimulates the body’s growth hormone-releasing pathway.
Tesamorelin is administered by subcutaneous injection.
Tesamorelin has potential risks and is not appropriate for everyone. Medical evaluation and appropriate monitoring are important before and during treatment.
Clinical studies have evaluated changes over several months rather than several days. Individual responses can vary substantially.
Alturas Medical Weight Loss provides physician-supervised peptide therapy from its Meridian clinic. The clinic serves Boise and communities throughout the Treasure Valley.
Tesamorelin is not appropriate for every patient. A medical evaluation can determine whether it fits your health history and treatment goals.
Alturas Medical Weight Loss provides physician-supervised peptide therapy in Meridian, near Boise.
